Altimmune, Inc. (ALT) Tops Q3 EPS by 4c

Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• SpaceX sets date for maiden earnings report: Why August 4 is make-or-break
• NVIDIA reports 9.3% passive stake in Nebius
• AdaptHealth to sell diabetes unit to Cardinal Health for $235M